Location History:
- Germantown, MD (US) (2011 - 2014)
- Gaithersburg, MD (US) (2016 - 2023)
Company Filing History:
20 out of 541 
3 out of 3 
2 out of 37 Years Active: 2011-2025
Title: **Melissa Marie Damschroder: Innovator in Biotherapeutics**
Introduction
Melissa Marie Damschroder is a distinguished inventor based in Gaithersburg, MD, recognized for her substantial contributions to the field of biotherapeutics. With an impressive portfolio of 24 patents, her work primarily focuses on novel binding molecules and methods that address critical health challenges.
Latest Patents
Among her recent innovations are two notable patents:
1. **ILT7 Binding Molecules and Methods of Using the Same** - This invention is aimed at ILT7 binding molecules, including anti-ILT7 antibodies. It offers potential methods for treating or preventing autoimmune diseases associated with ILT7-expressing cells.
2. **Antibodies Directed Against Leukotoxins** - This patent discloses leukotoxin-binding antibodies and their antigen-binding fragments. These antibodies can be utilized to detect leukotoxins and serve in therapeutic methods for preventing infections.
Career Highlights
Damschroder has built a significant career, working with renowned companies such as MedImmune Limited and Boston Pharmaceuticals, Inc. Her expertise in developing innovative therapies has made her a valuable asset in these organizations.
Collaborations
Throughout her career, Melissa has collaborated with notable colleagues, including Qun Du and Scott A Hammond. These partnerships have contributed to her successful patent applications and advancements in her field.
Conclusion
Melissa Marie Damschroder exemplifies the spirit of innovation in the biotherapeutics sector, with her patents paving the way for new treatment strategies against significant health issues. Her achievements reflect her dedication to improving healthcare outcomes through scientific discovery and collaboration.